Authorized Share Capital
Authorized share capital is the maximum number of shares a company is legally permitted to issue to shareholders, as stated in its constitutional documents—typically the Articles of Incorporation or Memorandum of Association. It represents a hard ceiling set by the company's founders (and later approved by shareholders) that limits how many shares can be distributed, whether through public offerings, private placements, or employee stock option plans. For example, if a corporation is authorized to issue 10 million shares of common stock, it cannot issue a single share beyond that number without formally amending its charter.
Short Definition
Authorized share capital is the maximum number of shares a company is legally permitted to issue to shareholders, as stated in its constitutional documents—typically the Articles of Incorporation or Memorandum of Association. It represents a hard ceiling set by the company's founders (and later approved by shareholders) that limits how many shares can be distributed, whether through public offerings, private placements, or employee stock option plans. For example, if a corporation is authorized to issue 10 million shares of common stock, it cannot issue a single share beyond that number without formally amending its charter.
What It Is
Authorized share capital is a foundational concept in corporate law and equity structure. When a company is incorporated, its founding documents specify a total number of shares the company may issue across one or more classes of stock. This figure—sometimes called "authorized capital" or "nominal capital"—acts as a legal boundary. The company does not need to issue all authorized shares at once. In practice, companies often authorize a large pool of shares but issue only a portion to investors, employees, and founders, retaining the rest for future fundraising, acquisitions, or strategic purposes.
The authorized share capital is typically broken down into classes. A company might authorize 50 million shares of common stock and 5 million shares of preferred stock, each with different voting rights, dividend preferences, and liquidation priorities. The par value—a nominal dollar amount assigned to each share, often as low as $0.00001 per share in Delaware-incorporated companies—is multiplied by the total authorized shares to determine the company's total authorized capital in dollar terms. For instance, a company authorizing 100 million shares at a par value of $0.001 per share has $100,000 in authorized capital on its books.
Importantly, authorized share capital is distinct from issued share capital (shares actually sold or granted to shareholders) and outstanding shares (issued shares still held by investors, excluding treasury shares the company has repurchased). A company authorized for 20 million shares might have issued only 12 million, leaving 8 million available for future issuance without shareholder approval to amend the corporate charter.
How It Works
Setting authorized share capital begins at incorporation. Founders work with their attorney or incorporation service to draft the Articles of Incorporation, specifying the total number of authorized shares and their par value. In the United States, Delaware—where over 65% of Fortune 500 companies are incorporated—imposes no minimum authorized share requirement, and filing fees are calculated based on the authorized share structure. A company authorizing 5 million shares or fewer pays the minimum franchise tax; authorizing 5,001 to 50,000 shares triggers incrementally higher fees, and the scale continues upward. This creates a real cost incentive to authorize only what is practical.
Once established, increasing authorized share capital requires a formal process. The board of directors must propose an amendment to the Articles of Incorporation, and shareholders must vote to approve it—typically requiring a majority or supermajority vote depending on the jurisdiction and the company's bylaws. This process can take weeks and involves filing amended articles with the state or relevant corporate registry. In the UK, under the Companies Act 2006, companies can increase authorized capital through an ordinary resolution (a simple majority of shareholders voting), though many newer UK companies have abolished the concept of authorized share capital entirely in favor of an "unlimited" model.
When a company wants to issue new shares from its authorized pool, the board typically approves the issuance through a board resolution. These new shares can be allocated for specific purposes: a Series B funding round might issue 2 million new shares to venture capital firms at $15 per share; an employee stock option plan might reserve 500,000 shares for distribution over four years; or a strategic acquisition might involve issuing 1 million shares as part of the purchase consideration. Each issuance reduces the pool of unissued authorized shares, and once the pool is exhausted, no further shares can be issued without the shareholder amendment process described above.
Practical Example
Consider a technology startup, NovaTech Inc., incorporated in Delaware in 2021. Its founders authorize 15 million shares of common stock at a par value of $0.0001 per share. At incorporation, the founders collectively hold 8 million shares (representing 100% ownership), the employee stock option pool is allocated 2 million shares, and 5 million shares remain unissued and available for future use.
By 2024, NovaTech has grown rapidly and seeks to raise $30 million in a Series B funding round. The company's lead investor, a venture capital firm, agrees to invest $30 million at a pre-money valuation of $120 million—implying a price of $15 per share (calculated as $120 million ÷ 8 million existing shares). To complete the round, NovaTech issues approximately 2 million new shares to the investor, bringing total issued shares to 12 million (8 million founder shares + 2 million option pool + 2 million Series B shares). The company still has 3 million authorized but unissued shares remaining for future rounds, acquisitions, or additional employee grants—all without needing to amend its charter. If NovaTech later needs to issue more than those 3 million remaining shares for a Series C round, it would need to hold a shareholder vote to increase its authorized share capital, a process that typically takes 4–8 weeks including state filing.
Why It Matters
For investors, authorized share capital is a critical lens for evaluating dilution risk. When you invest in a company, you want to understand not just how many shares are currently outstanding, but how many could be issued. A company with 10 million shares outstanding but 50 million authorized shares has the theoretical capacity to quintuple the share count, potentially diluting your ownership stake dramatically. Savvy investors and venture capitalists often negotiate protective provisions—such as anti-dilution clauses or the right to approve future issuances—to guard against this risk.
For business owners, authorized share capital is a strategic planning tool. Authorizing too few shares can create costly delays when you need to raise capital quickly—imagine being in the middle of a funding round and discovering you need 6–8 weeks to hold a shareholder vote to increase your authorized shares while your competitor closes their round first. Conversely, authorizing an excessively large number of shares can increase franchise tax obligations unnecessarily. In Delaware, authorizing 500 million shares (as some large tech companies do) costs significantly more in annual franchise taxes than authorizing 50 million. The sweet spot depends on your growth trajectory, funding needs, and tax optimization strategy.
Limitations and Risks
One common misconception is that authorized shares represent the total value or market capitalization of a company. They do not. Authorized share capital is purely a legal ceiling on share count—it says nothing about the price per share, the company's earnings, or its market value. A company authorized for 1 billion shares trading at $0.50 per share has a fundamentally different profile than one authorized for 10 million shares trading at $500 per share.
Another risk involves the interaction between authorized share capital and stock splits. If a company has 10 million authorized shares, 8 million issued, and wants to execute a 4-for-1 stock split, it would need 32 million authorized shares to accommodate the post-split share count—but only 10 million are available. Without first increasing authorized capital, the split cannot proceed. This has caught off-guard companies in fast-moving markets. Additionally, in some jurisdictions, particularly in parts of Europe and Asia, minimum authorized capital requirements still apply (for example, the UK historically required a minimum of £50,000 in authorized capital for public limited companies), which can create barriers to entry for startups and small businesses.
FAQ
What happens if a company runs out of authorized shares?
The company cannot issue any new shares until it formally increases its authorized share capital. This requires board approval, a shareholder vote (typically a majority or supermajority), and filing amended articles with the state or corporate registry. The process can take 4–8 weeks and may involve legal fees ranging from $500 for a simple Delaware amendment to several thousand dollars for more complex filings across multiple jurisdictions.
Can a company have more authorized shares than it has issued?
Yes—and in fact, this is the norm. Most companies deliberately authorize significantly more shares than they initially issue. A typical early-stage startup might authorize 10–20 million shares but issue only 5–8 million at founding. The unissued shares serve as a reserve for future fundraising rounds, employee equity grants, acquisitions, and strategic partnerships, all without requiring a shareholder vote each time new shares are needed.
Does authorized share capital affect a company's stock price?
Not directly. Authorized share capital is a legal and structural concept, not a market-driven one. However, it can indirectly affect stock price through dilution expectations. If investors believe a large pool of authorized-but-unissued shares could be issued in the future—potentially diluting earnings per share—they may apply a discount when valuing the stock. Conversely, a company that has already issued most of its authorized shares may face upward pressure on its stock price if demand for shares exceeds supply, since the company would need to go through the time-consuming process of increasing authorized capital before issuing more shares.
Bottom Line
Authorized share capital is the legal maximum number of shares a company can issue, and it sits at the intersection of corporate law, fundraising strategy, and investor protection. Whether you are a founder structuring your startup's initial incorporation or an investor evaluating dilution risk in a potential investment, understanding the authorized-issued-outstanding share hierarchy is essential. Before incorporating, consult with a corporate attorney to set your authorized share capital at a level that balances flexibility for future fundraising against unnecessary tax costs. And before investing, always check a company's authorized share count relative to its issued shares—because the gap between those two numbers represents the dilution that could be coming your way.
Which related MoneyBestPal guides should you read?
Use this topic as part of a wider finance toolkit. Related areas to review include:
Educational disclaimer: This MoneyBestPal article is for general financial education only. It is not investment, tax, legal, or accounting advice. Consider speaking with a qualified professional before making decisions based on your personal situation.
